Literature DB >> 3571427

The effect of a low fat diet on estrogen metabolism.

C Longcope, S Gorbach, B Goldin, M Woods, J Dwyer, A Morrill, J Warram.   

Abstract

Women who consume a diet low in fat are at lower risk for breast cancer than women whose diet is relatively high in fat. To investigate the effects of a low fat diet on estrogen metabolism, six normal young women were studied while eating a Western-style high fat diet and again after 2 months of consuming a defined low fat diet. Both studies involved the simultaneous administration of [3H]estradiol [( 3H]E2) orally and [14C]E2 iv and the subsequent collection of multiple blood samples and urine for 96 h. The blood samples were analyzed for radioactivity as estrone (E1), E2, their glucuronides, and E1 sulfate. An aliquot of the pooled 96-h urine was analyzed for radioactivity as the glucuronides and sulfates of E1, E2, estriol, 16 alpha-hydroxyestrone (16 alpha-OHE1), and the catechol estrogens, i.e. 2-hydroxy and 2-methoxy metabolites of E1 and E2. The low fat diet resulted in a consistent and significant (P less than 0.05) decrease in urinary excretion of both 16-hydroxylated metabolites, estriol and 16 alpha-OHE1, expressed as a percentage of administered dose of [3H]E2 and [14C]E2, and an increase in the excretion of the catechol estrogens. These changes in metabolite excretion were not, however, mirrored by changes in the MCRs or conversion ratios of either [3H]E2 or [14C]E2. Thus, while neither the clearance of E2 from the blood nor its absorption from the intestinal tract was altered by a relatively short term decrease in dietary fat, there was a shift in the pattern of urinary metabolites away from the purported carcinogenic estrogen (16 alpha-OHE1) and toward the less active catechol estrogens. This may represent an important mechanism whereby low fat diets decrease the risk of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571427     DOI: 10.1210/jcem-64-6-1246

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Diet and risk of endometriosis in a population-based case-control study.

Authors:  Britton Trabert; Ulrike Peters; Anneclaire J De Roos; Delia Scholes; Victoria L Holt
Journal:  Br J Nutr       Date:  2010-09-28       Impact factor: 3.718

Review 2.  Nutrition and endometrial cancer.

Authors:  H A Hill; H Austin
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

Review 3.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

4.  Fat/fiber intakes and sex hormones in healthy premenopausal women in USA.

Authors:  Mylène Aubertin-Leheudre; Sherwood Gorbach; Margo Woods; Johanna T Dwyer; Barry Goldin; Herman Adlercreutz
Journal:  J Steroid Biochem Mol Biol       Date:  2008-08-09       Impact factor: 4.292

5.  Dietary habits and mammographic patterns in patients with breast cancer.

Authors:  E Nordevang; E Azavedo; G Svane; B Nilsson; L E Holm
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

6.  Fruit intake associated with urinary estrogen metabolites in healthy premenopausal women.

Authors:  Kerryn W Reding; Charlotte Atkinson; Kim C Westerlind; Frank Stanczyk; Erin J Aiello Bowles; Mellissa Yong; Katherine M Newton; Johanna W Lampe
Journal:  Open J Prev Med       Date:  2012-02-23

7.  A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

Authors:  G Ursin; S London; F Z Stanczyk; E Gentzschein; A Paganini-Hill; R K Ross; M C Pike
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

8.  Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.

Authors:  R G Ziegler; S C Rossi; T R Fears; H L Bradlow; H Adlercreutz; D Sepkovic; P Kiuru; K Wahala; J B Vaught; J L Donaldson; R T Falk; C M Fillmore; P K Siiteri; R N Hoover; M H Gail
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

9.  Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study.

Authors:  Michael N Okobia; Clareann H Bunker; Seymour J Garte; Joseph M Zmuda; Emmanuel R Ezeome; Stanley Nc Anyanwu; Emmanuel Eo Uche; Usifo Osime; Joseph Ojukwu; Lewis H Kuller; Robert E Ferrell; Emanuela Taioli
Journal:  Infect Agent Cancer       Date:  2009-02-10       Impact factor: 2.965

10.  Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up.

Authors:  E N Meilahn; B De Stavola; D S Allen; I Fentiman; H L Bradlow; D W Sepkovic; L H Kuller
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.